You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PLOS this week: CLCA2 expression linked to survival among African-American women with aggressive breast cancer, gene alterations linked to hearing loss, and more.
The company's cofounders have developed methods for analyzing genetic material from fetal trophoblast cells isolated from the cervix.
In PLOS this week: transcription levels linked to uracil mutations, transcriptomic analysis of medicinal leech, and more.
Variants in CETP-inhibitor and statin target genes helped investigators untangle complex ties between low-density lipoprotein levels and cardiovascular events.
Investigators identified candidate protein markers from aptamer-based proteomic profiles of samples from women with or without late-onset preeclampsia.
Several academic and commercial groups are developing clinical cell-based noninvasive prenatal tests, which could eventually compete with current cell-free NIPTs.
The team has been monitoring changes in host gene expression patterns due to different types of infections, and hopes to develop a diagnostic test.
The grant, worth $1.4 million in its first year, will be used to develop a panel of RNA expression signatures that can diagnose infections in febrile infants.
The five-year grant will support optimizing the use of polymyxin B to treat Gram-negative bacterial infections and identify protein biomarkers of drug-associated toxicity.
Scientists from Wayne State University have found a set of 648 sperm RNA elements that could predict male fertility and help inform couples trying to conceive.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.